Get started
Author

Harish D. Rao

Observed names: Harish Rao, Rao, Harish
Observed institution: Serum Institute of India (India)
ORCID: 0000-0002-2836-7408
Observed ORCID: 0000-0002-2836-7408
OpenAlex ID: A5008194289
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
2024 · Mehreen S Datoo, Alassane Dicko, et al. · The Lancet · 450
PDF
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
2023 · Hitt Sharma, Sameer Parekh, et al. · The Lancet Oncology · 53
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
2022 · Neil C. Dalvie, Lisa H. Tostanoski, et al. · Science Advances · 32
PDF
Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii
2021 · Neil C. Dalvie, Andrew M. Biedermann, et al. · Biotechnology and Bioengineering · 29
PDF
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin
2023 · Vishal Rathod, Laxmikant Kadam, et al. · Frontiers in Immunology · 15
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
2022 · Kaushal Jerajani, Ying Wan, et al. · Journal of Pharmaceutical Sciences · 13
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
2022 · Ting Y. Wong, Brynnan P. Russ, et al. · mSphere · 12
Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines
2019 · Laxmikant Kadam, Krunal Patel, et al. · Methods · 12
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
2023 · Gaurav Nagar, Siddharth Jain, et al. · Vaccines · 9
PDF
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
2022 · Nitya Sharma, Kaushal Jerajani, et al. · Journal of Pharmaceutical Sciences · 7
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
2022 · Kaushal Jerajani, Ying Wan, et al. · Journal of Pharmaceutical Sciences · 7
PDF
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
2022 · Sergio A. Rodriguez-Aponte, Neil C. Dalvie, et al. · Vaccine · 6
Quantitative bead–based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples
2025 · Vishal Rathod, Sagar Katke, et al. · Frontiers in Immunology · 4
PDF
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
2023 · Hitt Sharma, K. Anil, et al. · Vaccine X · 3
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
2021 · Hitt Sharma, K. Anil, et al. · Vaccine · 3
Destabilising Effect of Class B CpG Adjuvants on Different Proteins and Vaccine Candidates
2025 · Kawkab Kanjo, Rakesh Lothe, et al. · Vaccines · 2
PDF
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany
2023 · Inci Aydin, Marcus May, et al. · Vaccine · 2
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
2023 · Hitt Sharma, Kiran Marthak, et al. · Vaccine X · 2
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
2023 · Hitt J Sharma, Sameer Parekh, et al. · Expert Review of Vaccines · 2
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant
2024 · Ria T. Caringal, John M. Hickey, et al. · Vaccines · 1
PDF
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant (Dataset)
2024 · Ria T. Caringal, John M. Hickey, et al.
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
2023 · Sharma, Hitt J, Parekh, Sameer, et al. · Figshare
Development and validation of bead-based assay quantifying Tetanus, Diphtheria, Pertussis Toxin, Filamentous haemagglutinin and Pertactin specific IgG in human serum
2022 · Vishal Rathod, Laxmikant Kadam, et al. · Research Square
PDF
Works count: 23
Citation count: 664
H-index: 9
I10-index: 8
Year
Topic
Type